June 28, 2017
Adults with long-standing type 2 diabetes who use injectable medications, such as insulin, or take at least 10 sick days per year are more likely to disclose their disease status to their employer than adults who take oral or no antidiabetic medications and have a shorter disease duration, according to findings from researchers in Denmark.
“People diagnosed with type 2 diabetes in Denmark are, with a handful of exceptions ... under no legal obligation to disclosure the condition to their employer,” Kasper Olesen, PhD, of the Steno Diabetes Center in Copenhagen, and colleagues wrote. “In most jobs, however, disclosure of diabetes at the workplace is necessary for optimal self-management during work hours. Nondisclosure may lead to impaired self-management behaviors, such as adverse eating, inexpedient consumption of medication, delayed glucose monitoring or delayed management of hypoglycemia.”